Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies

References

• Fridman WH, Zitvogel L, Sautes-Fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 2017;14(12):717–16. doi:10.1038/nrclinonc.2017.101.
   PubMed Web of Science ®Google Scholar
• Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. Natural innate and adaptive immunity to cancer. Annu Rev Immunol. 2011;29(1):235–271. doi:10.1146/annurev-immunol-031210-101324.
   PubMed Web of Science ®Google Scholar
• Petitprez F. B cells are associated with survival and immunotherapy response in sarcoma. Nature. 2020;577(7791):556–560. doi:10.1038/s41586-019-1906-8.
   PubMed Web of Science ®Google Scholar
• Helmink BA. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577(7791):549–555. doi:10.1038/s41586-019-1922-8.
   PubMed Web of Science ®Google Scholar
• Cabrita R. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature. 2020;577(7791):561–565. doi:10.1038/s41586-019-1914-8.
   PubMed Web of Science ®Google Scholar
• Girard JP, Moussion C, Forster R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol. 2012;12(11):762–773. doi:10.1038/nri3298.
   PubMed Web of Science ®Google Scholar
• Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol. 2014;32(1):659–702. doi:10.1146/annurev-immunol-032713-120145.
   PubMed Web of Science ®Google Scholar
• Lian J, Luster AD. Chemokine-guided cell positioning in the lymph node orchestrates the generation of adaptive immune responses. Curr Opin Cell Biol. 2015;36:1–6. doi:10.1016/j.ceb.2015.05.003.
   PubMed Web of Science ®Google Scholar
• Tellier J, Nutt SL. Plasma cells: the programming of an antibody-secreting machine. Eur J Immunol. 2019;49(1):30–37. doi:10.1002/eji.201847517.
   PubMed Web of Science ®Google Scholar
• Nutt SL, Hodgkin PD, Tarlinton DM, Corcoran LM. The generation of antibody-secreting plasma cells. Nat Rev Immunol. 2015;15(3):160–171. doi:10.1038/nri3795.
   PubMed Web of Science ®Google Scholar
• Sharonov GV, Serebrovskaya EO, Yuzhakova DV, Britanova OV, Chudakov DM. B cells, plasma cells and antibody repertoires in the tumour microenvironment. Nat Rev Immunol. 2020;20(5):294–307. doi:10.1038/s41577-019-0257-x.
   PubMed Web of Science ®Google Scholar
• Pitzalis C, Jones GW, Bombardieri M, Jones SA. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev Immunol. 2014;14(7):447–462. doi:10.1038/nri3700.
   PubMed Web of Science ®Google Scholar
• Sautes-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19(6):307–325. doi:10.1038/s41568-019-0144-6.
   PubMed Web of Science ®Google Scholar
• Martinet L. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res. 2011;71(17):5678–5687. doi:10.1158/0008-5472.CAN-11-0431.
   PubMed Web of Science ®Google Scholar
• Martinet L. High endothelial venules (HEVs) in human melanoma lesions: major gateways for tumor-infiltrating lymphocytes. Oncoimmunology. 2012;1(6):829–839. doi:10.4161/onci.20492.
   PubMed Web of Science ®Google Scholar
• Kalialis LV, Drzewiecki KT, Klyver H. Spontaneous regression of metastases from melanoma: review of the literature. Melanoma Res. 2009;19(5):275–282. doi:10.1097/CMR.0b013e32832eabd5.
   PubMed Web of Science ®Google Scholar
• Meier D. Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. Immunity. 2007;26(5):643–654. doi:10.1016/j.immuni.2007.04.009.
   PubMed Web of Science ®Google Scholar
• Hess E. RANKL induces organized lymph node growth by stromal cell proliferation. J Immunol. 2012;188(3):1245–1254. doi:10.4049/jimmunol.1101513.
   PubMed Web of Science ®Google Scholar
• Yoshida H. Different cytokines induce surface lymphotoxin-alphabeta on IL-7 receptor-alpha cells that differentially engender lymph nodes and peyer’s patches. Immunity. 2002;17(6):823–833. doi:10.1016/S1074-7613(02)00479-X.
   PubMed Web of Science ®Google Scholar
• Luther SA, Ansel KM, Cyster JG. Overlapping roles of CXCL13, interleukin 7 receptor alpha, and CCR7 ligands in lymph node development. J Exp Med. 2003;197(9):1191–1198. doi:10.1084/jem.20021294.
   PubMed Web of Science ®Google Scholar
• Takatori H. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med. 2009;206(1):35–41. doi:10.1084/jem.20072713.
   PubMed Web of Science ®Google Scholar
• Drayton DL, Ying X, Lee J, Lesslauer W, Ruddle NH. Ectopic LT alpha beta directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J Exp Med. 2003;197(9):1153–1163. doi:10.1084/jem.20021761.
   PubMed Web of Science ®Google Scholar
• Mueller CG, Hess E. Emerging functions of RANKL in lymphoid tissues. Front Immunol. 2012;3:261. doi:10.3389/fimmu.2012.00261.
   PubMed Web of Science ®Google Scholar
• Cupedo T. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol. 2009;10(1):66–74. doi:10.1038/ni.1668.
   PubMed Web of Science ®Google Scholar
• Luther SA. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol. 2002;169:424–433.
   PubMed Web of Science ®Google Scholar
• Chyou S. Fibroblast-type reticular stromal cells regulate the lymph node vasculature. J Immunol. 2008;181(6):3887–3896. doi:10.4049/jimmunol.181.6.3887.
   PubMed Web of Science ®Google Scholar
• Webster B. Regulation of lymph node vascular growth by dendritic cells. J Exp Med. 2006;203(8):1903–1913. doi:10.1084/jem.20052272.
   PubMed Web of Science ®Google Scholar
• Ager A. High endothelial venules and other blood vessels: critical regulators of lymphoid organ development and function. Front Immunol. 2017;8:45. doi:10.3389/fimmu.2017.00045.
   PubMed Web of Science ®Google Scholar
• Chyou S. Coordinated regulation of lymph node vascular-stromal growth first by CD11c+ cells and then by T and B cells. J Immunol. 2011;187:5558–5567. doi:10.4049/jimmunol.1101724.
   PubMed Web of Science ®Google Scholar
• Peske JD. Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. Nat Commun. 2015;6(1):7114. doi:10.1038/ncomms8114.
   PubMed Web of Science ®Google Scholar
• De Togni P. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science. 1994;264(5159):703–707. doi:10.1126/science.8171322.
   PubMed Web of Science ®Google Scholar
• Eberl G. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol. 2004;5(1):64–73. doi:10.1038/ni1022.
   PubMed Web of Science ®Google Scholar
• Kiyono H, Fukuyama S. NALT- versus peyer’s-patch-mediated mucosal immunity. Nat Rev Immunol. 2004;4(9):699–710. doi:10.1038/nri1439.
   PubMed Web of Science ®Google Scholar
• Nagatake T. Id2-, RORgammat-, and LTbetaR-independent initiation of lymphoid organogenesis in ocular immunity. J Exp Med. 2009;206(11):2351–2364. doi:10.1084/jem.20091436.
   PubMed Web of Science ®Google Scholar
• Lochner M. Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORgamma t and LTi cells. J Exp Med. 2011;208(1):125–134. doi:10.1084/jem.20100052.
   PubMed Web of Science ®Google Scholar
• Furtado GC. TNFalpha-dependent development of lymphoid tissue in the absence of RORgammat(+) lymphoid tissue inducer cells. Mucosal Immunol. 2014;7(3):602–614. doi:10.1038/mi.2013.79.
   PubMed Web of Science ®Google Scholar
• Rangel-Moreno J. The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol. 2011;12(7):639–646. doi:10.1038/ni.2053.
   PubMed Web of Science ®Google Scholar
• Tsuji M. Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity. 2008;29(2):261–271. doi:10.1016/j.immuni.2008.05.014.
   PubMed Web of Science ®Google Scholar
• Lochner M. Tertiary lymphoid tissues in the colon: friend and foe. Gut Microbes. 2011;2(3):193–197. doi:10.4161/gmic.2.3.16732.
   PubMed Web of Science ®Google Scholar
• Moyron-Quiroz JE. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med. 2004;10(9):927–934. doi:10.1038/nm1091.
   PubMed Web of Science ®Google Scholar
• De Chaisemartin L. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Res. 2011;71(20):6391–6399. doi:10.1158/0008-5472.CAN-11-0952.
   PubMed Web of Science ®Google Scholar
• Ansel KM. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature. 2000;406(6793):309–314. doi:10.1038/35018581.
   PubMed Web of Science ®Google Scholar
• Meylan M. Early hepatic lesions display immature tertiary lymphoid structures and show elevated expression of immune inhibitory and immunosuppressive molecules. Clin Cancer Res. 2020;26(16):4381–4389. doi:10.1158/1078-0432.CCR-19-2929.
   PubMed Web of Science ®Google Scholar
• Ladanyi A. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Cancer Immunol Immunother. 2007;56(9):1459–1469. doi:10.1007/s00262-007-0286-3.
   PubMed Web of Science ®Google Scholar
• Dieu-Nosjean MC. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol. 2008;26(27):4410–4417. doi:10.1200/JCO.2007.15.0284.
   PubMed Web of Science ®Google Scholar
• Kroeger DR, Milne K, Nelson BH. Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-Cell responses, and superior prognosis in ovarian cancer. Clin Cancer Res. 2016;22(12):3005–3015. doi:10.1158/1078-0432.CCR-15-2762.
   PubMed Web of Science ®Google Scholar
• Posch F. Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer. Oncoimmunology. 2018;7(2):e1378844. doi:10.1080/2162402X.2017.1378844.
   PubMed Web of Science ®Google Scholar
• Silina K. Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma. Cancer Res. 2018;78(5):1308–1320. doi:10.1158/0008-5472.CAN-17-1987.
   PubMed Web of Science ®Google Scholar
• Gu-Trantien C. CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer. JCI Insight. 2017;2(11). doi:10.1172/jci.insight.91487.
   PubMed Web of Science ®Google Scholar
• Messina JL. 12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?. Sci Rep. 2012;2(1):765. doi:10.1038/srep00765.
   PubMed Web of Science ®Google Scholar
• Coppola D. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am J Pathol. 2011;179(1):37–45. doi:10.1016/j.ajpath.2011.03.007.
   PubMed Web of Science ®Google Scholar
• Tokunaga R. 12-Chemokine signature, a predictor of tumor recurrence in colorectal cancer. Int J Cancer. 2020;147(2):532–541. doi:10.1002/ijc.32982.
   PubMed Web of Science ®Google Scholar
• Prabhakaran S. Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes. Breast Cancer Res. 2017;19(1):71. doi:10.1186/s13058-017-0864-z.
   PubMed Web of Science ®Google Scholar
• Gu-Trantien C. CD4(+) follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest. 2013;123(7):2873–2892. doi:10.1172/JCI67428.
   PubMed Web of Science ®Google Scholar
• Hennequin A. Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients. Oncoimmunology. 2016;5(2):e1054598. doi:10.1080/2162402X.2015.1054598.
   PubMed Web of Science ®Google Scholar
• Germain C. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med. 2014;189(7):832–844. doi:10.1164/rccm.201309-1611OC.
   PubMed Web of Science ®Google Scholar
• Tang J. B Cells and tertiary lymphoid structures influence survival in lung cancer patients with resectable tumors. Cancers (Basel). 2020;12(9). doi:10.3390/cancers12092644.
   Web of Science ®Google Scholar
• Li Q. Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma. Int J Oral Sci. 2020;12(1):24. doi:10.1038/s41368-020-00092-3.
   PubMed Web of Science ®Google Scholar
• Lee HJ. Prognostic significance of tumor-infiltrating lymphocytes and the tertiary lymphoid structures in HER2-positive breast cancer treated with adjuvant trastuzumab. Am J Clin Pathol. 2015;144(2):278–288. doi:10.1309/AJCPIXUYDVZ0RZ3G.
   PubMed Web of Science ®Google Scholar
• Figenschau SL, Fismen S, Fenton KA, Fenton C, Mortensen ES. Tertiary lymphoid structures are associated with higher tumor grade in primary operable breast cancer patients. BMC Cancer. 2015;15(1):101. doi:10.1186/s12885-015-1116-1.
   PubMed Web of Science ®Google Scholar
• Lee HJ. Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer. J Clin Pathol. 2016;69(5):422–430. doi:10.1136/jclinpath-2015-203089.
   PubMed Web of Science ®Google Scholar
• Di Caro G. Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers. Clin Cancer Res. 2014;20(8):2147–2158. doi:10.1158/1078-0432.CCR-13-2590.
   PubMed Web of Science ®Google Scholar
• Hill DG. Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development. Int J Cancer. 2018;143(1):167–178. doi:10.1002/ijc.31298.
   PubMed Web of Science ®Google Scholar
• Yamakoshi Y. Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer. Int J Oncol. 2020;57(1):171–182. doi:10.3892/ijo.2020.5042.
   PubMed Web of Science ®Google Scholar
• Calderaro J. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma. J Hepatol. 2019;70(1):58–65. doi:10.1016/j.jhep.2018.09.003.
   PubMed Web of Science ®Google Scholar
• Chen L. The immunosuppressive niche of soft tissue sarcomas is sustained by tumor associated macrophages and characterized by intratumoral tertiary lymphoid structures. Clin Cancer Res. 2020;15. doi:10.1158/1078-0432.CCR-19-3416.
   Web of Science ®Google Scholar
• Lin Q. Tumor-associated tertiary lymphoid structure predicts postoperative outcomes in patients with primary gastrointestinal stromal tumors. Oncoimmunology. 2020;9(1):1747339. doi:10.1080/2162402X.2020.1747339.
   PubMed Web of Science ®Google Scholar
• Hulsen S. High stroma T-Cell infiltration is associated with better survival in stage pT1 bladder cancer. Int J Mol Sci. 2020;21(21). doi:10.3390/ijms21218407.
   PubMed Web of Science ®Google Scholar
• Truxova I. Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients. J Immunother Cancer. 2018;6(1):139. doi:10.1186/s40425-018-0446-3.
   PubMed Web of Science ®Google Scholar
• Cipponi A. Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases. Cancer Res. 2012;72(16):3997–4007. doi:10.1158/0008-5472.CAN-12-1377.
   PubMed Web of Science ®Google Scholar
• Goc J. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T Cells. Cancer Res. 2014;74(3):705–715. doi:10.1158/0008-5472.CAN-13-1342.
   PubMed Web of Science ®Google Scholar
• Van Dijk N. Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial. Nat Med. 2020;12. doi:10.1038/s41591-020-1085-z.
   Web of Science ®Google Scholar
• Jiang Q. CD19(+) tumor-infiltrating B-cells prime CD4(+) T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer. Cancer Immunol Immunother. 2019;68(1):45–56. doi:10.1007/s00262-018-2250-9.
   PubMed Web of Science ®Google Scholar
• Welinder C. Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer. Heliyon. 2016;2(8):e00143. doi:10.1016/j.heliyon.2016.e00143.
   PubMedGoogle Scholar
• Mohammed ZM, Going JJ, Edwards J, Elsberger B, McMillan DC. The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer. Br J Cancer. 2013;109(6):1676–1684. doi:10.1038/bjc.2013.493.
   PubMed Web of Science ®Google Scholar
• Xu Y, Lan S, Zheng Q. Prognostic significance of infiltrating immune cell subtypes in invasive ductal carcinoma of the breast. Tumori. 2018;104(3):196–201. doi:10.5301/tj.5000624.
   PubMed Web of Science ®Google Scholar
• Mohammed ZM. The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer. Br J Cancer. 2012;107(5):864–873. doi:10.1038/bjc.2012.347.
   PubMed Web of Science ®Google Scholar
• Mahmoud SM. The prognostic significance of B lymphocytes in invasive carcinoma of the breast. Breast Cancer Res Treat. 2012;132(2):545–553. doi:10.1007/s10549-011-1620-1.
   PubMed Web of Science ®Google Scholar
• Brown JR. Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer. Clin Cancer Res. 2014;20(23):5995–6005. doi:10.1158/1078-0432.CCR-14-1622.
   PubMed Web of Science ®Google Scholar
• Garaud S. Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer. JCI Insight. 2019;5(18):e129641. doi: 10.1172/jci.insight.129641.
   PubMedGoogle Scholar
• Song IH. Predictive value of tertiary lymphoid structures assessed by high endothelial venule counts in the neoadjuvant setting of triple-negative breast cancer. Cancer Res Treat. 2017;49(2):399–407. doi:10.4143/crt.2016.215.
   PubMed Web of Science ®Google Scholar
• Garcia-Martinez E. Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer. Breast Cancer Res. 2014;16(6):488. doi:10.1186/s13058-014-0488-5.
   PubMed Web of Science ®Google Scholar
• Berntsson J, Nodin B, Eberhard J, Micke P, Jirstrom K. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer. Int J Cancer. 2016;139(5):1129–1139. doi:10.1002/ijc.30138.
   PubMed Web of Science ®Google Scholar
• Kasajima A. Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer. Hum Pathol. 2010;41(12):1758–1769. doi:10.1016/j.humpath.2010.05.014.
   PubMed Web of Science ®Google Scholar
• Mlecnik B. Comprehensive intrametastatic immune quantification and major impact of Immunoscore on survival. J Natl Cancer Inst. 2018;110(1). doi:10.1093/jnci/djx123.
   PubMedGoogle Scholar
• Meshcheryakova A. B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer. PLoS One. 2014;9(6):e99008. doi:10.1371/journal.pone.0099008.
   PubMed Web of Science ®Google Scholar
• Knief J. High density of tumor-infiltrating B-Lymphocytes and plasma cells signifies prolonged overall survival in adenocarcinoma of the esophagogastric junction. Anticancer Res. 2016;36(10):5339–5345. doi:10.21873/anticanres.11107.
   PubMed Web of Science ®Google Scholar
• Fristedt R. Prognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma. J Gastrointest Oncol. 2016;7(6):848–859. doi:10.21037/jgo.2016.11.07.
   PubMed Web of Science ®Google Scholar
• Yakirevich E. Prognostic significance of IgG4+ plasma cell infiltrates following neoadjuvant chemoradiation therapy for esophageal adenocarcinoma. Hum Pathol. 2017;66:126–135. doi:10.1016/j.humpath.2017.06.009.
   PubMed Web of Science ®Google Scholar
• Zheng X. Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a meta-analysis. Oncotarget. 2017;8(34):57386–57398. doi:10.18632/oncotarget.18065.
   PubMedGoogle Scholar
• Miyatani K. A high number of IgG4-positive cells in gastric cancer tissue is associated with tumor progression and poor prognosis. Virchows Arch. 2016;468(5):549–557. doi:10.1007/s00428-016-1914-0.
   PubMed Web of Science ®Google Scholar
• Garnelo M. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Gut. 2017;66(2):342–351. doi:10.1136/gutjnl-2015-310814.
   PubMed Web of Science ®Google Scholar
• Shi JY. Margin-infiltrating CD20+ B Cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma. Clin Cancer Res. 2013;19(21):5994–6005. doi:10.1158/1078-0432.CCR-12-3497.
   PubMed Web of Science ®Google Scholar
• Brunner SM. Tumor-infiltrating B cells producing antitumor active immunoglobulins in resected HCC prolong patient survival. Oncotarget. 2017;8(41):71002–71011. doi:10.18632/oncotarget.20238.
   PubMedGoogle Scholar
• Shalapour S. Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. Nature. 2017;551(7680):340–345. doi:10.1038/nature24302.
   PubMed Web of Science ®Google Scholar
• Iglesia MD. Genomic analysis of immune cell infiltrates across 11 tumor types. J Natl Cancer Inst. 2016;108(11). doi:10.1093/jnci/djw144.
   PubMedGoogle Scholar
• Sjoberg E. A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis. Br J Cancer. 2018;119(7):840–846. doi:10.1038/s41416-018-0266-8.
   PubMed Web of Science ®Google Scholar
• Charoentong P. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248–262. doi:10.1016/j.celrep.2016.12.019.
   PubMed Web of Science ®Google Scholar
• Kurebayashi Y. Comprehensive immune profiling of lung adenocarcinomas reveals four immunosubtypes with plasma cell subtype a negative indicator. Cancer Immunol Res. 2016;4(3):234–247. doi:10.1158/2326-6066.CIR-15-0214.
   PubMed Web of Science ®Google Scholar
• Lohr M. The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer. Cancer Lett. 2013;333(2):222–228. doi:10.1016/j.canlet.2013.01.036.
   PubMed Web of Science ®Google Scholar
• Schmidt M. A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin kappa C as a compatible prognostic marker in human solid tumors. Clin Cancer Res. 2012;18(9):2695–2703. doi:10.1158/1078-0432.CCR-11-2210.
   PubMed Web of Science ®Google Scholar
• Gentles AJ. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. 2015;21(8):938–945. doi:10.1038/nm.3909.
   PubMed Web of Science ®Google Scholar
• Isaeva OI. Intratumoral immunoglobulin isotypes predict survival in lung adenocarcinoma subtypes. J Immunother Cancer. 2019;7(1):279. doi:10.1186/s40425-019-0747-1.
   PubMedGoogle Scholar
• Fujimoto M. Stromal plasma cells expressing immunoglobulin G4 subclass in non-small cell lung cancer. Hum Pathol. 2013;44(8):1569–1576. doi:10.1016/j.humpath.2013.01.002.
   PubMed Web of Science ®Google Scholar
• Erdag G. Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Res. 2012;72(5):1070–1080. doi:10.1158/0008-5472.CAN-11-3218.
   PubMed Web of Science ®Google Scholar
• Garg K. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome. Hum Pathol. 2016;54:157–164. doi:10.1016/j.humpath.2016.03.022.
   PubMed Web of Science ®Google Scholar
• Bosisio FM. Plasma cells in primary melanoma. Prognostic significance and possible role of IgA. Mod Pathol. 2016;29(4):347–358. doi:10.1038/modpathol.2016.28.
   PubMed Web of Science ®Google Scholar
• Mose LE. Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V’DJer. Bioinformatics. 2016;32(24):3729–3734. doi:10.1093/bioinformatics/btw526.
   PubMed Web of Science ®Google Scholar
• Bolotin DA. Antigen receptor repertoire profiling from RNA-seq data. Nat Biotechnol. 2017;35(10):908–911. doi:10.1038/nbt.3979.
   PubMed Web of Science ®Google Scholar
• Chee SJ. Evaluating the effect of immune cells on the outcome of patients with mesothelioma. Br J Cancer. 2017;117(9):1341–1348. doi:10.1038/bjc.2017.269.
   PubMed Web of Science ®Google Scholar
• Ujiie H. The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: a comprehensive analysis reveals prognostic immune markers. Oncoimmunology. 2015;4(6):e1009285. doi:10.1080/2162402X.2015.1009285.
   PubMed Web of Science ®Google Scholar
• Lundgren S, Berntsson J, Nodin B, Micke P, Jirstrom K. Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer. J Ovarian Res. 2016;9(1):21. doi:10.1186/s13048-016-0232-0.
   PubMed Web of Science ®Google Scholar
• Iglesia MD. Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer. Clin Cancer Res. 2014;20(14):3818–3829. doi:10.1158/1078-0432.CCR-13-3368.
   PubMed Web of Science ®Google Scholar
• Nielsen JS. CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer. Clin Cancer Res. 2012;18:3281–3292. doi:10.1158/1078-0432.CCR-12-0234.
   PubMed Web of Science ®Google Scholar
• Milne K. Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS One. 2009;4(7):e6412. doi:10.1371/journal.pone.0006412.
   PubMed Web of Science ®Google Scholar
• Tewari N. The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays. BMC Cancer. 2013;13(1):436. doi:10.1186/1471-2407-13-436.
   PubMed Web of Science ®Google Scholar
• Miksch RC. Prognostic impact of tumor-infiltrating lymphocytes and neutrophils on survival of patients with upfront resection of pancreatic cancer. Cancers (Basel). 2019;11(1). doi:10.3390/cancers11010039.
   PubMed Web of Science ®Google Scholar
• Liu Q. Immunoglobulin G4 (IgG4)-positive plasma cell infiltration is associated with the clinicopathologic traits and prognosis of pancreatic cancer after curative resection. Cancer Immunol Immunother. 2016;65(8):931–940. doi:10.1007/s00262-016-1853-2.
   PubMed Web of Science ®Google Scholar
• Shalapour S. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature. 2015;521(7550):94–98. doi:10.1038/nature14395.
   PubMed Web of Science ®Google Scholar
• Lao XM. Distribution and significance of interstitial fibrosis and stroma-infiltrating B cells in tongue squamous cell carcinoma. Oncol Lett. 2016;11(3):2027–2034. doi:10.3892/ol.2016.4184.
   PubMed Web of Science ®Google Scholar
• Zhang Y. Mammary-tumor-educated B cells acquire LAP/TGF-beta and PD-L1 expression and suppress anti-tumor immune responses. Int Immunol. 2016;28(9):423–433. doi:10.1093/intimm/dxw007.
   PubMed Web of Science ®Google Scholar
• Sarvaria A, Madrigal JA, Saudemont A. B cell regulation in cancer and anti-tumor immunity. Cell Mol Immunol. 2017;14(8):662–674. doi:10.1038/cmi.2017.35.
   PubMed Web of Science ®Google Scholar
• Ladanyi A. Prognostic impact of B-cell density in cutaneous melanoma. Cancer Immunol Immunother. 2011;60(12):1729–1738. doi:10.1007/s00262-011-1071-x.
   PubMed Web of Science ®Google Scholar
• Castino GF. Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma. Oncoimmunology. 2016;5(4):e1085147. doi:10.1080/2162402X.2015.1085147.
   PubMed Web of Science ®Google Scholar
• Hamanaka Y. Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer. Int J Cancer. 2003;103(1):97–100. doi:10.1002/ijc.10801.
   PubMed Web of Science ®Google Scholar
• Kurtenkov O. Humoral immune response to MUC1 and to the thomsen-friedenreich (TF) glycotope in patients with gastric cancer: relation to survival. Acta Oncol. 2007;46(3):316–323. doi:10.1080/02841860601055441.
   PubMed Web of Science ®Google Scholar
• Schmidt M. The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res. 2008;68(13):5405–5413. doi:10.1158/0008-5472.CAN-07-5206.
   PubMed Web of Science ®Google Scholar
• Ammirante M, Luo JL, Grivennikov S, Nedospasov S, Karin M. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature. 2010;464(7286):302–305. doi:10.1038/nature08782.
   PubMed Web of Science ®Google Scholar
• Xiao X. PD-1hi identifies a novel regulatory B-cell population in human hepatoma that promotes disease progression. Cancer Discov. 2016;6:546–559. doi:10.1158/2159-8290.CD-15-1408.
   PubMed Web of Science ®Google Scholar
• Ye L. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1(+) regulatory B cell expansion. J Immunother Cancer. 2018;6(1):145. doi:10.1186/s40425-018-0451-6.
   PubMed Web of Science ®Google Scholar
• Murakami Y. Increased regulatory B cells are involved in immune evasion in patients with gastric cancer. Sci Rep. 2019;9(1):13083. doi:10.1038/s41598-019-49581-4.
   PubMed Web of Science ®Google Scholar
• Zhou X, Su YX, Lao XM, Liang YJ, Liao GQ. CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells. Oral Oncol. 2016;53:27–35. doi:10.1016/j.oraloncology.2015.11.003.
   PubMed Web of Science ®Google Scholar
• Wu H. PD-L1(+) regulatory B cells act as a T cell suppressor in a PD-L1-dependent manner in melanoma patients with bone metastasis. Mol Immunol. 2020;119:83–91. doi:10.1016/j.molimm.2020.01.008.
   PubMed Web of Science ®Google Scholar
• Das S, Bar-Sagi D. BTK signaling drives CD1d(hi)CD5(+) regulatory B-cell differentiation to promote pancreatic carcinogenesis. Oncogene. 2019;38(17):3316–3324. doi:10.1038/s41388-018-0668-3.
   PubMed Web of Science ®Google Scholar
• Cottrell TR. Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC). Ann Oncol. 2018;29(8):1853–1860. doi:10.1093/annonc/mdy218.
   PubMed Web of Science ®Google Scholar
• Lin Z. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure. Sci Rep. 2020;10(1):21530. doi:10.1038/s41598-020-78560-3.
   PubMed Web of Science ®Google Scholar
• Remark R. Immune contexture and histological response after neoadjuvant chemotherapy predict clinical outcome of lung cancer patients. Oncoimmunology. 2016;5(12):e1255394. doi:10.1080/2162402X.2016.1255394.
   PubMed Web of Science ®Google Scholar
• Franz L. Postoperative radiotherapy for laryngeal cancer. the prognostic role of programmed death-ligand 1: an immune microenvironment-based cluster analysis. Pathol Res Pract. 2020;216(9):153120. doi:10.1016/j.prp.2020.153120.
   PubMed Web of Science ®Google Scholar
• Maldonado L. Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions. Sci Transl Med. 2014;6(221):221ra213. doi:10.1126/scitranslmed.3007323.
   Web of Science ®Google Scholar
• Lutz ER. Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation. Cancer Immunol Res. 2014;2(7):616–631. doi:10.1158/2326-6066.CIR-14-0027.
   PubMed Web of Science ®Google Scholar
• Kratz A, Campos-Neto A, Hanson MS, Ruddle NH. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med. 1996;183(4):1461–1472. doi:10.1084/jem.183.4.1461.
   PubMed Web of Science ®Google Scholar
• Johansson-Percival A. De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors. Nat Immunol. 2017;18(11):1207–1217. doi:10.1038/ni.3836.
   PubMed Web of Science ®Google Scholar
• Weinstein AM. Tbet and IL-36gamma cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment. Oncoimmunology. 2017;6(6):e1322238. doi:10.1080/2162402X.2017.1322238.
   PubMed Web of Science ®Google Scholar
• Kirk CJ, Hartigan-O’Connor D, Mule JJ. The dynamics of the T-cell antitumor response: chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally. Cancer Res. 2001;61:8794–8802.
   PubMed Web of Science ®Google Scholar
• Kirk CJ. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. Cancer Res. 2001;61:2062–2070.
   PubMed Web of Science ®Google Scholar
• Yang SC. Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Cancer Res. 2006;66(6):3205–3213. doi:10.1158/0008-5472.CAN-05-3619.
   PubMed Web of Science ®Google Scholar
• Lee JM. Phase I trial of intratumoral injection of CCL21 gene-modified dendritic cells in lung cancer elicits tumor-specific immune responses and CD8(+) T-cell infiltration. Clin Cancer Res. 2017;23:4556–4568. doi:10.1158/1078-0432.CCR-16-2821.
   PubMed Web of Science ®Google Scholar
• DiLillo DJ, Yanaba K, Tedder TF. B Cells are required for optimal CD4 + and CD8 + T Cell tumor immunity: therapeutic B Cell depletion enhances B16 melanoma growth in mice. J Immunol. 2010;184(7):4006–4016. doi:10.4049/jimmunol.0903009.
   PubMed Web of Science ®Google Scholar
• David JM. A novel bifunctional anti-PD-L1/TGF-beta trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells. Oncoimmunology. 2017;6(10):e1349589. doi:10.1080/2162402X.2017.1349589.
   PubMed Web of Science ®Google Scholar
• Strauss J. Phase I trial of M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGFbeta, in advanced solid tumors. Clin Cancer Res. 2018;24(6):1287–1295. doi:10.1158/1078-0432.CCR-17-2653.
   PubMed Web of Science ®Google Scholar
• Lind H. Dual targeting of TGF-beta and PD-L1 via a bifunctional anti-PD-L1/TGF-betaRII agent: status of preclinical and clinical advances. J Immunother Cancer. 2020;8(1). doi:10.1136/jitc-2019-000433.
   Web of Science ®Google Scholar
• Knudson KM. M7824, a novel bifunctional anti-PD-L1/TGFbeta trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine. Oncoimmunology. 2018;7(5):e1426519. doi:10.1080/2162402X.2018.1426519.
   PubMed Web of Science ®Google Scholar
• Lan Y. Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-beta. Sci Transl Med. 2018;10(424). doi:10.1126/scitranslmed.aan5488.
   PubMed Web of Science ®Google Scholar
• Joshi NS. Regulatory T Cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T Cell responses. Immunity. 2015;43(3):579–590. doi:10.1016/j.immuni.2015.08.006.
   PubMed Web of Science ®Google Scholar
• Munoz-Erazo L, Rhodes JL, Marion VC, Kemp RA. Tertiary lymphoid structures in cancer - considerations for patient prognosis. Cell Mol Immunol. 2020;17(6):570–575. doi:10.1038/s41423-020-0457-0.
   PubMed Web of Science ®Google Scholar
• Yamaguchi K. Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer. Oncoimmunology. 2020;9(1):1724763. doi:10.1080/2162402X.2020.1724763.
   PubMed Web of Science ®Google Scholar
• Hofman P. Multiplexed immunohistochemistry for molecular and immune profiling in lung cancer-just about ready for prime-time?. Cancers (Basel). 2019;11(3). doi:10.3390/cancers11030283.
   Web of Science ®Google Scholar
• Parra ER, Francisco-Cruz A, Wistuba II. State-of-the-art of profiling immune contexture in the era of multiplexed staining and digital analysis to study paraffin tumor tissues. Cancers (Basel). 2019;11(2). doi:10.3390/cancers11020247.
   Web of Science ®Google Scholar
• Lin JR. Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes. Elife. 2018;7. doi:10.7554/eLife.31657.
   Web of Science ®Google Scholar
• Schurch CM. Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front. Cell. 2020;182(5):1341–1359 e1319. doi:10.1016/j.cell.2020.07.005.
   PubMed Web of Science ®Google Scholar